Overview
Familial glucocorticoid deficiency (FGD) is an autosomal recessive condition characterized by impaired adrenal cortisol production in response to adrenocorticotropic hormone (ACTH). It can arise from mutations in the ACTH receptor gene or other genetic loci, leading to adrenal insufficiency 3.Diagnosis
Clinical Presentation: Symptoms include hypoglycemia, hyperpigmentation, and failure to thrive in pediatric patients 3.
Laboratory Findings: Elevated ACTH levels with low cortisol and often low or normal aldosterone levels 3.
Genetic Testing: Mutation analysis of the ACTH receptor gene and other linked loci (e.g., D18S40 marker) to identify genetic defects 3.
Response to ACTH Stimulation Test: Typically shows an inadequate cortisol response 3.Management
Glucocorticoid Replacement: Lifelong replacement therapy with hydrocortisone or other glucocorticoids tailored to individual needs 3.
Monitoring: Regular assessment of cortisol levels and clinical symptoms to adjust dosing 3.
No Specific Therapeutics for LCAT Deficiency: While related to lipid metabolism, no specific treatments are currently available for the renal complications seen in some genetic contexts 1.Special Populations
Pediatrics: Early diagnosis and prompt glucocorticoid replacement are crucial to prevent developmental delays and metabolic complications 3.
Comorbidities: Cases with concurrent renal issues, such as those seen in LCAT deficiency, require careful monitoring and supportive care 1.Key Recommendations
Genetic Testing for Diagnosis: Identify mutations in the ACTH receptor gene or other linked loci to confirm FGD 3 (Evidence: Strong).
Initiate Glucocorticoid Replacement Therapy: Start lifelong hydrocortisone or equivalent to manage adrenal insufficiency 3 (Evidence: Strong).
Regular Monitoring of Cortisol Levels: Ensure appropriate dosing and clinical response through periodic assessments 3 (Evidence: Moderate).References
1 Vitali C, Bajaj A, Nguyen C, Schnall J, Chen J, Stylianou K et al.. A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency. Journal of lipid research 2022. link
2 Warriar N, Pagé N, Govindan MV. Expression of human glucocorticoid receptor gene and interaction of nuclear proteins with the transcriptional control element. The Journal of biological chemistry 1996. link
3 Weber A, Clark AJ. Mutations of the ACTH receptor gene are only one cause of familial glucocorticoid deficiency. Human molecular genetics 1994. link
4 Groyer A, Le Bouc Y, Joab I, Radanyi C, Renoir JM, Robel P et al.. Chick oviduct glucocorticosteroid receptor. Specific binding of the synthetic steroid RU 486 and immunological studies with antibodies to chick oviduct progesterone receptor. European journal of biochemistry 1985. link
5 Okret S, Carlstedt-Duke J, Wrange O, Carlström K, Gustafsson JA. Characterization of an antiserum against the glucocorticoid receptor. Biochimica et biophysica acta 1981. link90087-8)